Study on Vitamin C , Thiamine and Hydrocortisone in Septic shock patients
- Conditions
- Health Condition 1: R652- Severe sepsis
- Registration Number
- CTRI/2024/07/070812
- Lead Sponsor
- Dasari Sai Divya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
(1) Patients in septic shock with vasopressor requirement : a continuous infusion of epinephrine, vasopressin, nor epinephrine, dopamine or other vasopressor agent at any dose required to maintain a mean arterial pressure of at least 65 mm hg despite intravenous crystalloid resuscitation of at least 30 ml/kg
(2) Suspected or confirmed infection as evidenced by the ordering of blood and urine cultures and the administration of at least one antimicrobial agent
(3) Patients who are candidates for ICU admission
(1) Shock due to other causes
(2) Limitations of care (defined as refusal of cardiovascular and respiratory support modes) including do not intubate status
(3) known allergy or known contraindication to Vitamin C , Thiamine , or corticosteroids
(4) Chronic illness / disease that, in opinion of the site investigator , has an expected life span of less than 30 days unrelated to current sepsis diagnosis ( example: stage IV malignancy and neurodegenerative disease )
(5) Pregnancy or known active breast feeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) Vasopressor and ventilator free days (VVFD) <br/ ><br>(2) SOFA score <br/ ><br>(3) New onset AKI resolutionTimepoint: (1) Vasopressor and ventilator free days (VVFD) at baseline, at 3 days, at 1 week, at 2 weeks, at 4 weeks. <br/ ><br>(2) SOFA score - initial assessment and at baseline, at 3 days, at 1 week, at 2 weeks, at 4 weeks. <br/ ><br>(3) New onset AKI resolution at baseline, at 3 days, at 1 week, at 2 weeks, at 4 weeks.
- Secondary Outcome Measures
Name Time Method Over all mortalityTimepoint: Over all mortality at baseline, at 3 days, at 1 week, at 2 weeks & at 4 weeks.